The global Prostate Cancer Diagnostics market is projected to grow from US$ 14570 million in 2024 to US$ 22860 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.8% during the forecast period.

Prostate Cancer Diagnostics Market

The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.

Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.

Market Analysis and Insights: Global Prostate Cancer Diagnostics Market

Market competition is intense. Genomic Health, Abbott, OPKO, Siemens Healthcare, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. Those key players got about 4% market shares. North America region is the largest region of Prostate Cancer Diagnostics, with a revenue market share nearly 49%. Europe is the second region of Prostate Cancer Diagnostics, enjoying revenue market share nearly 28%.

Report Covers:

This report presents an overview of global market for Prostate Cancer Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Prostate Cancer Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Prostate Cancer Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Prostate Cancer Diagnostics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Prostate Cancer Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Prostate Cancer Diagnostics revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Prostate Cancer Diagnostics Market Report

Report Metric	Details
Report Name	Prostate Cancer Diagnostics Market
Accounted market size in 2024	US$ 14570 million
Forecasted market size in 2030	US$ 22860 million
CAGR	7.8
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Tumor Biomarker Tests Imaging Biopsy Other
Segment by Application	Age Below 55 Age 55-75 Age Above 75
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	OPKO, Genomic Health, Abbott, Beckman Coulter, Siemens Healthcare, bioMeriux, Roche, MDx Health, DiaSorin, Myriad Genetics, Ambry Genetics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Prostate Cancer Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer Diagnostics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prostate Cancer Diagnostics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Prostate Cancer Diagnostics Market growing?

Ans: The Prostate Cancer Diagnostics Market witnessing a CAGR of 7.8 during the forecast period 2024-2030.

What is the Prostate Cancer Diagnostics Market size in 2030?

Ans: The Prostate Cancer Diagnostics Market size in 2030 will be US$ 22860 million.

What is the Prostate Cancer Diagnostics Market share by region?

Ans: North America region is the largest region of Prostate Cancer Diagnostics, with a revenue market share nearly 49%. Europe is the second region of Prostate Cancer Diagnostics, enjoying revenue market share nearly 28%.

Who are the main players in the Prostate Cancer Diagnostics Market report?

Ans: The main players in the Prostate Cancer Diagnostics Market are OPKO, Genomic Health, Abbott, Beckman Coulter, Siemens Healthcare, bioMeriux, Roche, MDx Health, DiaSorin, Myriad Genetics, Ambry Genetics

What are the Application segmentation covered in the Prostate Cancer Diagnostics Market report?

Ans: The Applications covered in the Prostate Cancer Diagnostics Market report are Age Below 55, Age 55-75, Age Above 75

What are the Type segmentation covered in the Prostate Cancer Diagnostics Market report?

Ans: The Types covered in the Prostate Cancer Diagnostics Market report are Tumor Biomarker Tests, Imaging, Biopsy, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Prostate Cancer Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Tumor Biomarker Tests

1.2.3 Imaging

1.2.4 Biopsy

1.2.5 Other

1.3 Market by Application

1.3.1 Global Prostate Cancer Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Age Below 55

1.3.3 Age 55-75

1.3.4 Age Above 75

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Prostate Cancer Diagnostics Market Perspective (2019-2030)

2.2 Global Prostate Cancer Diagnostics Growth Trends by Region

2.2.1 Prostate Cancer Diagnostics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Prostate Cancer Diagnostics Historic Market Size by Region (2019-2024)

2.2.3 Prostate Cancer Diagnostics Forecasted Market Size by Region (2025-2030)

2.3 Prostate Cancer Diagnostics Market Dynamics

2.3.1 Prostate Cancer Diagnostics Industry Trends

2.3.2 Prostate Cancer Diagnostics Market Drivers

2.3.3 Prostate Cancer Diagnostics Market Challenges

2.3.4 Prostate Cancer Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Prostate Cancer Diagnostics by Players

3.1.1 Global Prostate Cancer Diagnostics Revenue by Players (2019-2024)

3.1.2 Global Prostate Cancer Diagnostics Revenue Market Share by Players (2019-2024)

3.2 Global Prostate Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Prostate Cancer Diagnostics, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Prostate Cancer Diagnostics Market Concentration Ratio

3.4.1 Global Prostate Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnostics Revenue in 2023

3.5 Global Key Players of Prostate Cancer Diagnostics Head office and Area Served

3.6 Global Key Players of Prostate Cancer Diagnostics, Product and Application

3.7 Global Key Players of Prostate Cancer Diagnostics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate Cancer Diagnostics Breakdown Data by Type

4.1 Global Prostate Cancer Diagnostics Historic Market Size by Type (2019-2024)

4.2 Global Prostate Cancer Diagnostics Forecasted Market Size by Type (2025-2030)

5 Prostate Cancer Diagnostics Breakdown Data by Application

5.1 Global Prostate Cancer Diagnostics Historic Market Size by Application (2019-2024)

5.2 Global Prostate Cancer Diagnostics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Prostate Cancer Diagnostics Market Size (2019-2030)

6.2 North America Prostate Cancer Diagnostics Market Size by Type

6.2.1 North America Prostate Cancer Diagnostics Market Size by Type (2019-2024)

6.2.2 North America Prostate Cancer Diagnostics Market Size by Type (2025-2030)

6.2.3 North America Prostate Cancer Diagnostics Market Share by Type (2019-2030)

6.3 North America Prostate Cancer Diagnostics Market Size by Application

6.3.1 North America Prostate Cancer Diagnostics Market Size by Application (2019-2024)

6.3.2 North America Prostate Cancer Diagnostics Market Size by Application (2025-2030)

6.3.3 North America Prostate Cancer Diagnostics Market Share by Application (2019-2030)

6.4 North America Prostate Cancer Diagnostics Market Size by Country

6.4.1 North America Prostate Cancer Diagnostics Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Prostate Cancer Diagnostics Market Size by Country (2019-2024)

6.4.3 North America Prostate Cancer Diagnostics Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Prostate Cancer Diagnostics Market Size (2019-2030)

7.2 Europe Prostate Cancer Diagnostics Market Size by Type

7.2.1 Europe Prostate Cancer Diagnostics Market Size by Type (2019-2024)

7.2.2 Europe Prostate Cancer Diagnostics Market Size by Type (2025-2030)

7.2.3 Europe Prostate Cancer Diagnostics Market Share by Type (2019-2030)

7.3 Europe Prostate Cancer Diagnostics Market Size by Application

7.3.1 Europe Prostate Cancer Diagnostics Market Size by Application (2019-2024)

7.3.2 Europe Prostate Cancer Diagnostics Market Size by Application (2025-2030)

7.3.3 Europe Prostate Cancer Diagnostics Market Share by Application (2019-2030)

7.4 Europe Prostate Cancer Diagnostics Market Size by Country

7.4.1 Europe Prostate Cancer Diagnostics Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Prostate Cancer Diagnostics Market Size by Country (2019-2024)

7.4.3 Europe Prostate Cancer Diagnostics Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Prostate Cancer Diagnostics Market Size (2019-2030)

8.2 China Prostate Cancer Diagnostics Market Size by Type

8.2.1 China Prostate Cancer Diagnostics Market Size by Type (2019-2024)

8.2.2 China Prostate Cancer Diagnostics Market Size by Type (2025-2030)

8.2.3 China Prostate Cancer Diagnostics Market Share by Type (2019-2030)

8.3 China Prostate Cancer Diagnostics Market Size by Application

8.3.1 China Prostate Cancer Diagnostics Market Size by Application (2019-2024)

8.3.2 China Prostate Cancer Diagnostics Market Size by Application (2025-2030)

8.3.3 China Prostate Cancer Diagnostics Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Prostate Cancer Diagnostics Market Size (2019-2030)

9.2 Asia Prostate Cancer Diagnostics Market Size by Type

9.2.1 Asia Prostate Cancer Diagnostics Market Size by Type (2019-2024)

9.2.2 Asia Prostate Cancer Diagnostics Market Size by Type (2025-2030)

9.2.3 Asia Prostate Cancer Diagnostics Market Share by Type (2019-2030)

9.3 Asia Prostate Cancer Diagnostics Market Size by Application

9.3.1 Asia Prostate Cancer Diagnostics Market Size by Application (2019-2024)

9.3.2 Asia Prostate Cancer Diagnostics Market Size by Application (2025-2030)

9.3.3 Asia Prostate Cancer Diagnostics Market Share by Application (2019-2030)

9.4 Asia Prostate Cancer Diagnostics Market Size by Region

9.4.1 Asia Prostate Cancer Diagnostics Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Prostate Cancer Diagnostics Market Size by Region (2019-2024)

9.4.3 Asia Prostate Cancer Diagnostics Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Prostate Cancer Diagnostics Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Prostate Cancer Diagnostics Market Size by Type

10.2.1 Middle East, Africa, and Latin America Prostate Cancer Diagnostics Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Prostate Cancer Diagnostics Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Prostate Cancer Diagnostics Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Prostate Cancer Diagnostics Market Size by Application

10.3.1 Middle East, Africa, and Latin America Prostate Cancer Diagnostics Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Prostate Cancer Diagnostics Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Prostate Cancer Diagnostics Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Prostate Cancer Diagnostics Market Size by Country

10.4.1 Middle East, Africa, and Latin America Prostate Cancer Diagnostics Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Prostate Cancer Diagnostics Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Prostate Cancer Diagnostics Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 OPKO

11.1.1 OPKO Company Details

11.1.2 OPKO Business Overview

11.1.3 OPKO Prostate Cancer Diagnostics Introduction

11.1.4 OPKO Revenue in Prostate Cancer Diagnostics Business (2019-2024)

11.1.5 OPKO Recent Developments

11.2 Genomic Health

11.2.1 Genomic Health Company Details

11.2.2 Genomic Health Business Overview

11.2.3 Genomic Health Prostate Cancer Diagnostics Introduction

11.2.4 Genomic Health Revenue in Prostate Cancer Diagnostics Business (2019-2024)

11.2.5 Genomic Health Recent Developments

11.3 Abbott

11.3.1 Abbott Company Details

11.3.2 Abbott Business Overview

11.3.3 Abbott Prostate Cancer Diagnostics Introduction

11.3.4 Abbott Revenue in Prostate Cancer Diagnostics Business (2019-2024)

11.3.5 Abbott Recent Developments

11.4 Beckman Coulter

11.4.1 Beckman Coulter Company Details

11.4.2 Beckman Coulter Business Overview

11.4.3 Beckman Coulter Prostate Cancer Diagnostics Introduction

11.4.4 Beckman Coulter Revenue in Prostate Cancer Diagnostics Business (2019-2024)

11.4.5 Beckman Coulter Recent Developments

11.5 Siemens Healthcare

11.5.1 Siemens Healthcare Company Details

11.5.2 Siemens Healthcare Business Overview

11.5.3 Siemens Healthcare Prostate Cancer Diagnostics Introduction

11.5.4 Siemens Healthcare Revenue in Prostate Cancer Diagnostics Business (2019-2024)

11.5.5 Siemens Healthcare Recent Developments

11.6 bioMeriux

11.6.1 bioMeriux Company Details

11.6.2 bioMeriux Business Overview

11.6.3 bioMeriux Prostate Cancer Diagnostics Introduction

11.6.4 bioMeriux Revenue in Prostate Cancer Diagnostics Business (2019-2024)

11.6.5 bioMeriux Recent Developments

11.7 Roche

11.7.1 Roche Company Details

11.7.2 Roche Business Overview

11.7.3 Roche Prostate Cancer Diagnostics Introduction

11.7.4 Roche Revenue in Prostate Cancer Diagnostics Business (2019-2024)

11.7.5 Roche Recent Developments

11.8 MDx Health

11.8.1 MDx Health Company Details

11.8.2 MDx Health Business Overview

11.8.3 MDx Health Prostate Cancer Diagnostics Introduction

11.8.4 MDx Health Revenue in Prostate Cancer Diagnostics Business (2019-2024)

11.8.5 MDx Health Recent Developments

11.9 DiaSorin

11.9.1 DiaSorin Company Details

11.9.2 DiaSorin Business Overview

11.9.3 DiaSorin Prostate Cancer Diagnostics Introduction

11.9.4 DiaSorin Revenue in Prostate Cancer Diagnostics Business (2019-2024)

11.9.5 DiaSorin Recent Developments

11.10 Myriad Genetics

11.10.1 Myriad Genetics Company Details

11.10.2 Myriad Genetics Business Overview

11.10.3 Myriad Genetics Prostate Cancer Diagnostics Introduction

11.10.4 Myriad Genetics Revenue in Prostate Cancer Diagnostics Business (2019-2024)

11.10.5 Myriad Genetics Recent Developments

11.11 Ambry Genetics

11.11.1 Ambry Genetics Company Details

11.11.2 Ambry Genetics Business Overview

11.11.3 Ambry Genetics Prostate Cancer Diagnostics Introduction

11.11.4 Ambry Genetics Revenue in Prostate Cancer Diagnostics Business (2019-2024)

11.11.5 Ambry Genetics Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Prostate Cancer Diagnostics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Tumor Biomarker Tests

Table 3. Key Players of Imaging

Table 4. Key Players of Biopsy

Table 5. Key Players of Other

Table 6. Global Prostate Cancer Diagnostics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global Prostate Cancer Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Prostate Cancer Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Prostate Cancer Diagnostics Market Share by Region (2019-2024)

Table 10. Global Prostate Cancer Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Prostate Cancer Diagnostics Market Share by Region (2025-2030)

Table 12. Prostate Cancer Diagnostics Market Trends

Table 13. Prostate Cancer Diagnostics Market Drivers

Table 14. Prostate Cancer Diagnostics Market Challenges

Table 15. Prostate Cancer Diagnostics Market Restraints

Table 16. Global Prostate Cancer Diagnostics Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Prostate Cancer Diagnostics Revenue Share by Players (2019-2024)

Table 18. Global Top Prostate Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics as of 2023)

Table 19. Global Prostate Cancer Diagnostics Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by Prostate Cancer Diagnostics Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Prostate Cancer Diagnostics, Headquarters and Area Served

Table 22. Global Key Players of Prostate Cancer Diagnostics, Product and Application

Table 23. Global Key Players of Prostate Cancer Diagnostics, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Prostate Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Prostate Cancer Diagnostics Revenue Market Share by Type (2019-2024)

Table 27. Global Prostate Cancer Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Prostate Cancer Diagnostics Revenue Market Share by Type (2025-2030)

Table 29. Global Prostate Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Prostate Cancer Diagnostics Revenue Share by Application (2019-2024)

Table 31. Global Prostate Cancer Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Prostate Cancer Diagnostics Revenue Share by Application (2025-2030)

Table 33. North America Prostate Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Prostate Cancer Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Prostate Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Prostate Cancer Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Prostate Cancer Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Prostate Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Prostate Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Prostate Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Prostate Cancer Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Prostate Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Prostate Cancer Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Prostate Cancer Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Prostate Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Prostate Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Prostate Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Prostate Cancer Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Prostate Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Prostate Cancer Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Prostate Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Prostate Cancer Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Prostate Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Prostate Cancer Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Prostate Cancer Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Prostate Cancer Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Prostate Cancer Diagnostics Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Prostate Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Prostate Cancer Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Prostate Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Prostate Cancer Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Prostate Cancer Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Prostate Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Prostate Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 65. OPKO Company Details

Table 66. OPKO Business Overview

Table 67. OPKO Prostate Cancer Diagnostics Product

Table 68. OPKO Revenue in Prostate Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 69. OPKO Recent Developments

Table 70. Genomic Health Company Details

Table 71. Genomic Health Business Overview

Table 72. Genomic Health Prostate Cancer Diagnostics Product

Table 73. Genomic Health Revenue in Prostate Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 74. Genomic Health Recent Developments

Table 75. Abbott Company Details

Table 76. Abbott Business Overview

Table 77. Abbott Prostate Cancer Diagnostics Product

Table 78. Abbott Revenue in Prostate Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 79. Abbott Recent Developments

Table 80. Beckman Coulter Company Details

Table 81. Beckman Coulter Business Overview

Table 82. Beckman Coulter Prostate Cancer Diagnostics Product

Table 83. Beckman Coulter Revenue in Prostate Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 84. Beckman Coulter Recent Developments

Table 85. Siemens Healthcare Company Details

Table 86. Siemens Healthcare Business Overview

Table 87. Siemens Healthcare Prostate Cancer Diagnostics Product

Table 88. Siemens Healthcare Revenue in Prostate Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 89. Siemens Healthcare Recent Developments

Table 90. bioMeriux Company Details

Table 91. bioMeriux Business Overview

Table 92. bioMeriux Prostate Cancer Diagnostics Product

Table 93. bioMeriux Revenue in Prostate Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 94. bioMeriux Recent Developments

Table 95. Roche Company Details

Table 96. Roche Business Overview

Table 97. Roche Prostate Cancer Diagnostics Product

Table 98. Roche Revenue in Prostate Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 99. Roche Recent Developments

Table 100. MDx Health Company Details

Table 101. MDx Health Business Overview

Table 102. MDx Health Prostate Cancer Diagnostics Product

Table 103. MDx Health Revenue in Prostate Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 104. MDx Health Recent Developments

Table 105. DiaSorin Company Details

Table 106. DiaSorin Business Overview

Table 107. DiaSorin Prostate Cancer Diagnostics Product

Table 108. DiaSorin Revenue in Prostate Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 109. DiaSorin Recent Developments

Table 110. Myriad Genetics Company Details

Table 111. Myriad Genetics Business Overview

Table 112. Myriad Genetics Prostate Cancer Diagnostics Product

Table 113. Myriad Genetics Revenue in Prostate Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 114. Myriad Genetics Recent Developments

Table 115. Ambry Genetics Company Details

Table 116. Ambry Genetics Business Overview

Table 117. Ambry Genetics Prostate Cancer Diagnostics Product

Table 118. Ambry Genetics Revenue in Prostate Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 119. Ambry Genetics Recent Developments

Table 120. Research Programs/Design for This Report

Table 121. Key Data Information from Secondary Sources

Table 122. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Prostate Cancer Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Prostate Cancer Diagnostics Market Share by Type: 2023 VS 2030

Figure 3. Tumor Biomarker Tests Features

Figure 4. Imaging Features

Figure 5. Biopsy Features

Figure 6. Other Features

Figure 7. Global Prostate Cancer Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Prostate Cancer Diagnostics Market Share by Application: 2023 VS 2030

Figure 9. Age Below 55 Case Studies

Figure 10. Age 55-75 Case Studies

Figure 11. Age Above 75 Case Studies

Figure 12. Prostate Cancer Diagnostics Report Years Considered

Figure 13. Global Prostate Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Prostate Cancer Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Prostate Cancer Diagnostics Market Share by Region: 2023 VS 2030

Figure 16. Global Prostate Cancer Diagnostics Market Share by Players in 2023

Figure 17. Global Top Prostate Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Prostate Cancer Diagnostics Revenue in 2023

Figure 19. North America Prostate Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Prostate Cancer Diagnostics Market Share by Type (2019-2030)

Figure 21. North America Prostate Cancer Diagnostics Market Share by Application (2019-2030)

Figure 22. North America Prostate Cancer Diagnostics Market Share by Country (2019-2030)

Figure 23. United States Prostate Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Prostate Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Prostate Cancer Diagnostics Market Size YoY (2019-2030) & (US$ Million)

Figure 26. Europe Prostate Cancer Diagnostics Market Share by Type (2019-2030)

Figure 27. Europe Prostate Cancer Diagnostics Market Share by Application (2019-2030)

Figure 28. Europe Prostate Cancer Diagnostics Market Share by Country (2019-2030)

Figure 29. Germany Prostate Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Prostate Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Prostate Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Prostate Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Prostate Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Prostate Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Prostate Cancer Diagnostics Market Size YoY (2019-2030) & (US$ Million)

Figure 36. China Prostate Cancer Diagnostics Market Share by Type (2019-2030)

Figure 37. China Prostate Cancer Diagnostics Market Share by Application (2019-2030)

Figure 38. Asia Prostate Cancer Diagnostics Market Size YoY (2019-2030) & (US$ Million)

Figure 39. Asia Prostate Cancer Diagnostics Market Share by Type (2019-2030)

Figure 40. Asia Prostate Cancer Diagnostics Market Share by Application (2019-2030)

Figure 41. Asia Prostate Cancer Diagnostics Market Share by Region (2019-2030)

Figure 42. Japan Prostate Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Prostate Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan Prostate Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Prostate Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Prostate Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Prostate Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Prostate Cancer Diagnostics Market Size YoY (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Prostate Cancer Diagnostics Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America Prostate Cancer Diagnostics Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America Prostate Cancer Diagnostics Market Share by Country (2019-2030)

Figure 52. Brazil Prostate Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico Prostate Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey Prostate Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Prostate Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel Prostate Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries Prostate Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. OPKO Revenue Growth Rate in Prostate Cancer Diagnostics Business (2019-2024)

Figure 59. Genomic Health Revenue Growth Rate in Prostate Cancer Diagnostics Business (2019-2024)

Figure 60. Abbott Revenue Growth Rate in Prostate Cancer Diagnostics Business (2019-2024)

Figure 61. Beckman Coulter Revenue Growth Rate in Prostate Cancer Diagnostics Business (2019-2024)

Figure 62. Siemens Healthcare Revenue Growth Rate in Prostate Cancer Diagnostics Business (2019-2024)

Figure 63. bioMeriux Revenue Growth Rate in Prostate Cancer Diagnostics Business (2019-2024)

Figure 64. Roche Revenue Growth Rate in Prostate Cancer Diagnostics Business (2019-2024)

Figure 65. MDx Health Revenue Growth Rate in Prostate Cancer Diagnostics Business (2019-2024)

Figure 66. DiaSorin Revenue Growth Rate in Prostate Cancer Diagnostics Business (2019-2024)

Figure 67. Myriad Genetics Revenue Growth Rate in Prostate Cancer Diagnostics Business (2019-2024)

Figure 68. Ambry Genetics Revenue Growth Rate in Prostate Cancer Diagnostics Business (2019-2024)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions